- Home
- TCMD vs ENLV Comparison
TCMD vs ENLV Comparison
Compare TCMD & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCMD | ENLV |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.1M | 249.3M |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TCMD | ENLV |
|---|---|---|
| Price | $27.88 | $1.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $27.00 | $13.00 |
| AVG Volume (30 Days) | 265.7K | ★ 515.9K |
| Earning Date | 02-17-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.66 | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $311,513,000.00 | N/A |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $8.82 | N/A |
| P/E Ratio | $36.41 | ★ N/A |
| Revenue Growth | ★ 9.28 | N/A |
| 52 Week Low | $8.61 | $0.66 |
| 52 Week High | $31.38 | $2.10 |
Technical Indicators
Market Signals| Indicator | TCMD | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 65.52 |
| Support Level | $27.00 | $1.01 |
| Resistance Level | $29.16 | $1.26 |
| Average True Range (ATR) | 1.11 | 0.09 |
| MACD | -0.37 | 0.01 |
| Stochastic Oscillator | 8.22 | 79.41 |
Price Performance
Historical ComparisonAbout TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.